What is Aledade?
Founded in 2014 and headquartered in Bethesda, Maryland, Aledade operates at the intersection of healthcare technology and clinical practice management. The company specializes in partnering with independent primary care physicians, clinics, and health centers to establish and lead Accountable Care Organizations (ACOs). By providing the necessary data analytics, regulatory expertise, and operational support, Aledade enables these smaller entities to thrive in a value-based reimbursement environment.
The company's market position is defined by its ability to bridge the gap between fragmented primary care and the complex requirements of modern healthcare reform. Through its proprietary technology platform, Aledade empowers providers to deliver proactive, coordinated care, which is essential for achieving the triple aim of better health, better care, and lower costs. As the industry shifts away from fee-for-service models, Aledade remains a critical partner for independent practices seeking to maintain their autonomy while achieving financial and clinical success.
How much funding has Aledade raised?
Aledade has raised a total of $897.7M across 9 funding rounds:
Series B
$40.2M
Private Equity
$23M
Private Equity
$23M
Series C
$64M
Series D
$100M
Series E
$123M
Series F
$260M
Series F
$260M
Series B (2016): $40.2M led by Maryland Venture Fund, Venrock, ARCH Venture Partners, Biomatics Capital, and GV
Private Equity (2017): $23M, investors not publicly disclosed
Private Equity (2018): $23M featuring Meritech
Series C (2020): $64M backed by Meritech Capital Partners, California Medical Association, Echo Health Ventures, GV, OMERS Growth Equity, and CVF
Series D (2021): $100M with participation from Meritech, IVP, OMERS Growth Equity, and TriplePoint Venture Growth BDC
Series E (2022): $123M led by Fidelity Management & Research Company and OMERS Growth Equity
Series F (2023): $260M supported by OMERS Growth Equity, Lightspeed Venture Partners, Venrock, and Avidity Partners
Series F (2023): $260M featuring Lightspeed Venture Partners, Avidity Partners, OMERS Growth Equity, and Venrock
Key Investors in Aledade
Venrock
A historic venture capital firm founded in 1969 that provides strategic guidance and entrepreneurial support to high-growth technology and healthcare ventures.
OMERS Growth Equity
A global investment firm that specializes in transforming mid-sized businesses into industry leaders through long-term partnerships and direct capital deployment.
Lightspeed Venture Partners
A global multi-stage venture capital firm that invests in early and growth-stage technology companies across sectors including enterprise software and fintech.
What's next for Aledade?
Looking ahead, the recent strategic financing will likely be deployed to accelerate the adoption of Aledade's ACO model in new geographic markets and to enhance its digital health capabilities. The company is expected to focus on deepening its integration with existing partner networks, ensuring that independent practices have the tools required to manage complex patient populations effectively. As the regulatory landscape continues to favor value-based care, Aledade's ability to scale its infrastructure will be paramount in maintaining its competitive advantage. The continued backing from institutional investors suggests a long-term commitment to the company's vision of a more efficient, patient-centered healthcare system.
See full Aledade company page
